Related content

Sudden hearing loss due to internal auditory canal metastasis of Her2positive gastric cancer: A case report

By          

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 394-396

Spandidos Publications

Access to resources Recommend Favorite

Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model

By        

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1087-1093

Spandidos Publications

Access to resources Recommend Favorite

The MicroRNA-21/PTEN Pathway Regulates the Sensitivity of HER2-Positive Gastric Cancer Cells to Trastuzumab

By Eto Kojiro   Iwatsuki Masaaki   Watanabe Masayuki   Ida Satoshi   Ishimoto Takatsugu   Iwagami Shiro   Baba Yoshifumi   Sakamoto Yasuo   Miyamoto Yuji   Yoshida Naoya   Baba Hideo  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 343-350

Springer Publishing Company

Access to resources Recommend Favorite

Treatment strategy for HER2-positive breast cancer

By Mukai Hirofumi  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 335-340

Springer Publishing Company

Access to resources Recommend Favorite

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

By Lipton Allan   Goodman Laurie   Leitzel Kim   Cook Jennifer   Sperinde Jeff   Haddad Mojgan   Köstler Wolfgang   Huang Weidong   Weidler Jodi   Ali Suhail   Newton Alicia   Fuchs Eva-Marie   Paquet Agnes   Singer Christian   Horvat Reinhard   Jin Xueguang   Banerjee Joyee   Mukherjee Ali   Tan Yuping   Shi Yining   Chenna Ahmed   Larson Jeff   Lie Yolanda   Sherwood Thomas   Petropoulos Christos   Williams Stephen   Winslow John   Parry Gordon   Bates Michael  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 43-53

Springer Publishing Company

Access to resources Recommend Favorite